Protagenic Therapeutics Inc. (PTIX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Protagenic Therapeutics I...

    NASDAQ: PTIX · Real-Time Price · USD
    3.29
    -0.01 (-0.30%)
    At close: Oct 03, 2025, 3:58 PM
    3.29
    0.00%
    After-hours: Oct 03, 2025, 04:43 PM EDT

    Protagenic Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -6.08 -12.04 -27.2 -63.19
    PEG Ratio
    		 3.50 -0.3 0.80 -2.63
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 33.18 16.42 13.98 28.75
    P/FCF Ratio
    		 -7.97 -15.63 -48.47 -102.13
    P/OCF Ratio
    		 -7.97 -16.26 -48.51 -102.13
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a n/a 0.05 0.03
    Quick Ratio
    		 2.00 6.41 7.18 13.83
    Current Ratio
    		 2.00 6.41 7.18 13.83
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a -42.04 -25.88 -8.33
    Return on Equity
    		 -5.45 -1.36 -0.51 -0.45
    Return on Assets
    		 -2.82 -1.16 -0.44 -0.41
    Return on Invested Capital
    		 -5.63 -1.23 -0.49 -0.4
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist